Bioneedles as vaccine carriers. (Q47777748)

5 February 2018

title

Bioneedles as vaccine carriers. (English)

1 reference

5 February 2018

author name string

Hoang J H B Hirschberg

1

1 reference

5 February 2018

Gijsbert G P van de Wijdeven

2

1 reference

5 February 2018

Annemarie B Kelder

3

1 reference

5 February 2018

Germie P J M van den Dobbelsteen

4

1 reference

5 February 2018

Gideon F A Kersten

5

1 reference

5 February 2018

language of work or name

English

0 references

publication date

25 March 2008

1 reference

5 February 2018

published in

Vaccine

1 reference

5 February 2018

volume

26

1 reference

5 February 2018

issue

19

1 reference

5 February 2018

page(s)

2389-2397

1 reference

5 February 2018

Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Preventing cold chain failure: vaccine storage and handling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Revolutionary vaccine technology breaks the cold chain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Making vaccines more acceptable--methods to prevent and minimize pain and other common adverse events associated with vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Combination vaccines: design strategies and future trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Vaccine delivery--current trends and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Needle-free vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Needle-free vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Immunization without needles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Novel approaches to vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Recent developments in vaccine delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

7 January 2021

Oral vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Pharmacokinetics and pharmacodynamics of a new formulation of recombinant human growth hormone administered by ZomaJet 2 Vision, a new needle-free device, compared to subcutaneous administration using a conventional syringe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Needle-free liquid jet injections: mechanisms and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Hepatitis A vaccine administration: comparison between jet-injector and needle injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Needle-free epidermal powder immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Immune responses to hepatitis B surface antigen following epidermal powder immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Transcutaneous immunization: a human vaccine delivery strategy using a patch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Antigens onto bare skin: a 'painless' paradigm shift in vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Immunity under the skin: potential application for topical delivery of vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Novel mechanisms and devices to enable successful transdermal drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Transdermal delivery of insulin using microneedles in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Microneedles for transdermal drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Development and assessment of mini projectiles as drug carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

The use of the in vitro toxin binding inhibition (ToBI) test for the estimation of the potency of tetanus toxoid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Stabilizing effect of four types of disaccharide on the enzymatic activity of freeze-dried lactate dehydrogenase: step by step evaluation from freezing to storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

A murine locus on chromosome 18 controls NKT cell homeostasis and Th cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

Non-major histocompatibility complex control of antibody isotype and Th1 versus Th2 cytokines during experimental infection of mice with Mycobacterium avium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.067

10.1016/J.VACCINE.2008.02.067

7 January 2021

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

18406021

1 reference

5 February 2018